Patient Access to ESRD New Innovative Devices Act
- Last Action
- 6/10/2021
Actions
- 2021-06-10Read twice and referred to the Committee on Finance.
- 2021-06-10Introduced in Senate
CRS Summary
As of 2021-06-10 (00)
Patient Access to ESRD New Innovative Devices Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must provide for a three-year temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD. (CMS regulations currently provide a two-year temporary add-on payment adjustment.)
Cosponsors (3)
- Kyrsten Sinema (D-AZ)
- Cindy Hyde-Smith (R-MS)
- Thomas Carper (D-DE)
Subjects
- Administrative law and regulatory procedures
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug safety, medical device, and laboratory regulation
- Health care coverage and access
- Health technology, devices, supplies
- Medical tests and diagnostic methods
- Medicare
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.